Keyphrases
Cognitive Dysfunction
100%
Amyloid-β Peptide
100%
Butyrylcholinesterase Inhibitors
100%
Rivastigmine
100%
Donepezil
66%
Alzheimer's Disease
33%
Memory Impairment
33%
Butyrylcholinesterase (BChE)
33%
Beneficial Effects
16%
Therapeutic Strategies
16%
Oxidative Damage
16%
Acetylcholinesterase Inhibition
16%
Selective Inhibitor
16%
Novel Object Recognition
16%
Recognition Memory
16%
Acetylcholinesterase Inhibitors (AChEI)
16%
Memory Acquisition
16%
Memory Consolidation
16%
Acetylcholinesterase and Butyrylcholinesterase
16%
Dual Inhibitor
16%
Acetylcholinesterase
16%
Imprinting Control Region
16%
Tyrosine Nitration
16%
Selective Butyrylcholinesterase Inhibitor
16%
Neuroscience
Cognitive Disorders
100%
Amyloid Protein
100%
Cholinesterase
100%
Rivastigmine
100%
Donepezil
66%
Acetylcholinesterase
50%
Memory Disorder
33%
Alzheimer's Disease
16%
Recognition Memory
16%
Treatment of Alzheimer's Disease
16%
Acetylcholinesterase Inhibitor
16%